Page 18 - வெர்டெக்ஸ் மருந்துகள் இணைக்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Hepatitis C Diagnosis & Treatment Market Outlook by Key Players, Industry Trends and Size, Forecast Analysis by 2025
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Vertex Announces New Drug Submission for Investigational Triple Combination Medicine for the Treatment of Cystic Fibrosis Has Been Accepted for Priority Review by Health Canada
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
Search jobs 23-Dec-2020 Global Hereditary Testing Market Recent Study including Growth Factors 2027 – Top Companies F. Hoffmann-La Roche Ltd, Abbott, Amgen Inc., ELITechGroup, GW Pharmaceuticals plc
The Global Hereditary Testing Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released by Data Bridge Market Research. This Global Hereditary Testing Market report provides explanation about the detailed market analysis with inputs from industry experts. Competitive landscape in this report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and strategies. The data and information regarding the industry are taken from trustworthy sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. Gaining valuable market insights with the new skills, latest tools and innovative programs is
Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
About Vertex Pharmaceuticals
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) a rare, life-threatening genetic disease and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.